Cyteir Therapeutics

Professional Services 📍 Lexington, United States 👥 1-10 employees 💰 $295.7M raised 📅 Founded 2012

Cyteir was a clinical-stage oncology company focused on the development of CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Cyteir had CYT-0851 in development in combination with capecitabine and gemcitabine in a Phase 1/2 clinical study, including patients with advanced ovarian cancer

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Professional Services

Country

United States

Employees

1-10

Est. Revenue

$14.6B

Founded

2012

Cloud

Unknown

CDN

Cloudflare

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Behind Cloudflare — actual host undetectable

Workspace	🔒 Subscribers only
CDN	Cloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$15K – $38K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from Cyteir Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Professional Services), similar size

ADVANCED DISPOSAL SERVICE

11-50 ☁️ Unknown

Integrity Marketing Group Inc

1-10 ☁️ AWS

1-10 ☁️ AWS

Data detected 2026-06-13 · Methodology · Suggest a correction